1. Home
  2. TXG vs RDI Comparison

TXG vs RDI Comparison

Compare TXG & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$17.99

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

RDI

Reading International Inc

HOLD

Current Price

$1.07

Market Cap

23.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
RDI
Founded
2012
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Movies/Entertainment
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
23.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TXG
RDI
Price
$17.99
$1.07
Analyst Decision
Hold
Analyst Count
14
0
Target Price
$16.18
N/A
AVG Volume (30 Days)
2.6M
36.0K
Earning Date
02-12-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$642,823,000.00
$211,292,000.00
Revenue This Year
$5.15
N/A
Revenue Next Year
N/A
$13.42
P/E Ratio
N/A
N/A
Revenue Growth
5.25
7.11
52 Week Low
$6.78
$1.00
52 Week High
$23.56
$1.65

Technical Indicators

Market Signals
Indicator
TXG
RDI
Relative Strength Index (RSI) 52.14 47.38
Support Level $17.26 $1.01
Resistance Level $19.43 $1.10
Average True Range (ATR) 1.17 0.04
MACD -0.28 0.00
Stochastic Oscillator 50.08 42.86

Price Performance

Historical Comparison
TXG
RDI

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: